Andrew McConaghie reports on a frank exchange of views about NHS finances and market access in the UKPharma's late-stage pipeline may be dominated by a new generation of specialist, often groundbreaking... Read more
Early access programmes offer the potential for gaining real-world evidence in the period between phase III and marketing authorisation, which could provide data to support the product's effectiveness and value... Read more
Christian Gardner, Director, Media Services at pharmaphorum marks Social Media Day by looking at pharma's progress in engaging patients and healthcare professionals via social media.
Did you know that today is... Read more
And with that Angela McFarlane brings things to a close with a
brief summary and some recommendations - increased transparency of
process and mandates of roles for the NHS, for the... Read more
Boehringer Ingelheim has secured first European approvals for its new once-daily treatment for chronic obstructive pulmonary disease, Spiolto Respimat.
The drug combines the long-acting muscarinic agonist tiotropium - the active ingredient... Read more
Patients with lung cancer in the UK can now get treatment with Bristol-Myers Squibb's Opdivo under a new scheme designed to accelerate access to new drugs.Opdivo (nivolumab) has been included... Read more
Physician education is undergoing a massive change as the volume of advances in therapies and practices increases and the use of digital channels facilitates new forms of scientific exchange. This white... View info
This comprehensive supplement brings together a series of articles, insights and discussions produced by Kantar Health in order to help stimulate debate and fresh thinking about the future of pharmaceutical... View info
Chronic obstructive pulmonary disease (COPD) is a progressive and debilitating disorder, which, as it progresses, places a significant burden on individuals and those caring for them. This is not only... View info
How can life science brands identify winning strategic decisions when there are so many variables to consider? One route is via 'road-testing' decisions ahead of sign-off under computer game simulated... View info